Trial Profile
A trial evaluating effect of pramlintide as adjunctive therapy on closed-loop insulin delivery in childrens with type-1-diabetes-mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 08 Jun 2016 New trial record
- 05 May 2016 Primary endpoint has been met. (Change in meal-stimulated plasma glucose excursions), as per an article published in the Diabetes Care
- 05 May 2016 Results of this and other trial (see profile 233245) published in the Diabetes Care